Hassane M. Zarour, MD, discusses the addition of antibiotics to immunotherapy treatment in patients with melanoma.
Hassane M. Zarour, MD, professor of medicine and immunology at the University of Pittsburgh, discusses the addition of antibiotics to immunotherapy treatment in patients with melanoma.
According to Zarour, clinicians should think twice about whether the patient needs antibiotics, because they could be deleterious to a specific therapy.
Brain Cancer Awareness Month: Challenges and Innovations in Treatment
May 13th 2024In an interview with Targeted Oncology for Brain Cancer Awareness Month, Theodore Schwartz, MD, discussed the challenges of targeting brain tumors, emerging therapies, and strategies to overcome the blood-brain barrier.
Read More